Lack of Efficacy of SGLT2-i in Severe Pneumonia Related to Novel Coronavirus (nCoV) Infection: No Little Help from Our Friends
Diabetes Ther
.
2020 Jul;11(7):1605-1606.
doi: 10.1007/s13300-020-00844-8.
Epub 2020 May 23.
Authors
Antonio Carlo Bossi
1
,
Franco Forloni
2
,
Paolo Luigi Colombelli
3
Affiliations
1
Endocrine Unit-Diabetes Regional Center, ASST Bergamo Ovest, Treviglio, BG, Italy. antonio_bossi@asst-bgovest.it.
2
Endocrine Unit-Diabetes Regional Center, ASST Bergamo Ovest, Treviglio, BG, Italy.
3
Internal Medicine Division, ASST Bergamo Ovest, Treviglio, BG, Italy.
PMID:
32447736
PMCID:
PMC7244936
DOI:
10.1007/s13300-020-00844-8
No abstract available
Keywords:
COVID-19 related pneumonia; Non-diabetic patients; SGLT2-inhibitors.
Publication types
Letter